KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TAK) FCF Payout Ratio (2018 - 2025)

Historic FCF Payout Ratio for Takeda Pharmaceutical (TAK) over the last 8 years, with Q4 2025 value amounting to 0.36.

  • Takeda Pharmaceutical's FCF Payout Ratio fell 590.94% to 0.36 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.25, marking a year-over-year increase of 48.57%. This contributed to the annual value of 0.3 for FY2025, which is 2226.3% down from last year.
  • As of Q4 2025, Takeda Pharmaceutical's FCF Payout Ratio stood at 0.36, which was down 590.94% from 0.02 recorded in Q3 2025.
  • Takeda Pharmaceutical's FCF Payout Ratio's 5-year high stood at 30.14 during Q1 2025, with a 5-year trough of 1.02 in Q2 2022.
  • For the 5-year period, Takeda Pharmaceutical's FCF Payout Ratio averaged around 1.64, with its median value being 0.18 (2022).
  • Its FCF Payout Ratio has fluctuated over the past 5 years, first plummeted by 12800.07% in 2023, then surged by 82838.29% in 2025.
  • Quarter analysis of 5 years shows Takeda Pharmaceutical's FCF Payout Ratio stood at 0.35 in 2021, then grew by 10.72% to 0.31 in 2022, then plummeted by 128.0% to 0.71 in 2023, then soared by 52.52% to 0.34 in 2024, then dropped by 5.91% to 0.36 in 2025.
  • Its last three reported values are 0.36 in Q4 2025, 0.02 for Q3 2025, and 0.55 during Q2 2025.